ArticleEuropean journal of clinical pharmacology2021

Is there association between clinically relevant toxicities of pazopanib and sunitinib with the use of weak CYP3A4 and P-gp inhibitors?

Setayesh Sadeghi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.